- CITATIONS: 1
|Application ||WB, IHC-P, FC, E|
|Other Accession||Q8R496, Q5IBH7|
|Calculated MW||36463 Da|
|Antigen Region||147-175 aa|
|Other Names||Speedy protein A, Rapid inducer of G2/M progression in oocytes A, RINGO A, hSpy/Ringo A, Speedy-1, Spy1, SPDYA (HGNC:30613)|
|Target/Specificity||This SPDYA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 147-175 amino acids from the Central region of human SPDYA.|
|Precautions||SPDYA Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Regulates the G1/S phase transition of the cell cycle by binding and activating CDK1, CDK2 and CDKN1B/KIP1. Can activate CDK2 without promoting CDK2 phosphorylation. Mediates cell survival during the DNA damage process through activation of CDK2.|
|Tissue Location||Highly expressed in testis. Expressed at a low level in wide range of tissues including bone marrow, brain, heart, kidney, colon, liver, placenta, spleen, skeletal muscle, salivary gland, thyroid gland, thymus, trachea and uterus Expressed at a slightly higher level in adrenal gland, cerebellum, small intestine, lung, prostate and trachea. Expression is cell cycle-dependent, being restricted to cells in G1/S phase|
Provided below are standard protocols that you may find useful for product applications.
SPDYA (speedy homolog A (Drosophila)) regulates the G1/S phase transition of the cell cycle by binding and activating CDC2, CDK2 and CDKN1B/KIP1. SPDYA can activate CDK2 without promoting CDK2 phosphorylation. SPDYA mediates cell survival during the DNA damage process through activation of CDK2.
Ke, Q., et al. Exp. Mol. Pathol. 87(3):167-172(2009)
Dinarina, A., et al. FEBS Lett. 583(17):2772-2778(2009)
McAndrew, C.W., et al. Cell Cycle 8(1):66-75(2009)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.